Literature DB >> 7768351

Flauoprotein structure and mechanism 2. Monoamine oxidases: old friends hold many surprises.

T P Singer1, R R Ramsay.   

Abstract

The two forms of monoamine oxidase (MAO), A and B, continue to be of major interest to biochemists, pharmacologists, neurologists, and gerontologists. Despite intensive study for more than half a century, unexpected and unique properties of these enzymes continue to come to light. Recent studies have centered on their kinetic mechanism, their unique predilection for substrates related to the neurotoxic tertiary amine MPTP, and their putative role in aging and in the etiology of neurodegenerative diseases. New and potent inhibitors of MAO A and MAO B continue to be developed because of their potential use in clinical medicine. Some are effective in the picomolar range but MAO B from different mammalian species shows remarkable differences in sensitivity to these agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768351     DOI: 10.1096/fasebj.9.8.7768351

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

1.  Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells.

Authors:  Sukhamoy Dhabal; Pradip Das; Pritam Biswas; Priyanka Kumari; Valentin P Yakubenko; Suman Kundu; Martha K Cathcart; Manjari Kundu; Kaushik Biswas; Ashish Bhattacharjee
Journal:  J Biol Chem       Date:  2018-07-18       Impact factor: 5.157

2.  Monoamine oxidase A (MAO-A): a signature marker of alternatively activated monocytes/macrophages.

Authors:  Martha K Cathcart; Ashish Bhattacharjee
Journal:  Inflamm Cell Signal       Date:  2014

Review 3.  Covalent attachment of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) to enzymes: the current state of affairs.

Authors:  M Mewies; W S McIntire; N S Scrutton
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

4.  The role of monoamine metabolism in oxidative glutamate toxicity.

Authors:  P Maher; J B Davis
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

5.  Computer visualisation of the active site of monoamine oxidase-A by means of selective inhibitors.

Authors:  Alexei E Medvedev; Alexis S Ivanov; Alexander V Veselovsky
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

6.  Implication for functions of the ectopic adipocyte copper amine oxidase (AOC3) from purified enzyme and cell-based kinetic studies.

Authors:  Sam H Shen; Diana L Wertz; Judith P Klinman
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

7.  Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat.

Authors:  Lucyna Antkiewicz-Michaluk; Agnieszka Wąsik; Edyta Możdżeń; Irena Romańska; Jerzy Michaluk
Journal:  Neurotox Res       Date:  2014-01-10       Impact factor: 3.911

8.  The Protective Effect of Repeated 1MeTIQ Administration on the Lactacystin-Induced Impairment of Dopamine Release and Decline in TH Level in the Rat Brain.

Authors:  Agnieszka Wąsik; Irena Romańska; Agnieszka Zelek-Molik; Irena Nalepa; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2018-08-20       Impact factor: 3.911

Review 9.  1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application.

Authors:  Lucyna Antkiewicz-Michaluk; Agnieszka Wąsik; Jerzy Michaluk
Journal:  Neurotox Res       Date:  2013-05-30       Impact factor: 3.911

10.  Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.

Authors:  Agnieszka Wąsik; Irena Romańska; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2016-08-27       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.